Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Foghorn Therapeutics (FHTX) Accumulated Depreciation & Amortization (2020 - 2025)

Foghorn Therapeutics has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at $3.3 million for Q4 2025.

  • Quarterly results put Accumulated Depreciation & Amortization at $3.3 million for Q4 2025, up 6.79% from a year ago — trailing twelve months through Dec 2025 was $3.3 million (up 6.79% YoY), and the annual figure for FY2025 was $3.3 million, up 6.79%.
  • Accumulated Depreciation & Amortization for Q4 2025 was $3.3 million at Foghorn Therapeutics, up from $900000.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for FHTX hit a ceiling of $3.5 million in Q4 2023 and a floor of $700000.0 in Q3 2024.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $900000.0 (2023), compared with a mean of $1.6 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: skyrocketed 213.73% in 2021 and later crashed 63.61% in 2023.
  • Foghorn Therapeutics' Accumulated Depreciation & Amortization stood at $3.2 million in 2021, then grew by 3.12% to $3.3 million in 2022, then grew by 4.58% to $3.5 million in 2023, then fell by 9.59% to $3.1 million in 2024, then rose by 6.79% to $3.3 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $3.3 million (Q4 2025), $900000.0 (Q3 2025), and $900000.0 (Q2 2025) per Business Quant data.